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Abstract.  Cells of the nonfusing muscle cell line 
BC3H1 stop proliferating  and express a  family of 
muscle-specific proteins when the FBS concentration 
is reduced from 20 to 0.5%  (Munson,  R.,  K.  L.  Cald- 
well, and  L. Glaser.  1982. J.  Cell Biol. 92:350-356). 
Several growth factors have been shown to block 
differentiation in this cell line.  To begin to investigate 
the potential  role of G proteins in signal transducing 
pathways from these receptors,  we have examined the 
effects of cholera toxin (CT) and pertussis toxin (PT) 
on proliferation and differentiation  in BC3H1 cells.  PT 
specifically ADP ribosylates a protein with an appar- 
ent molecular mass of 40 kD in BC3H1 cell mem- 
branes,  whereas CT specifically ADP ribosylates three 
proteins of 35-43 kD.  When added to exponentially 
growing cells in 20%  FBS, CT and  PT inhibited 
[3H]thymidine  incorporation by up to 75 % in a dose- 
dependent fashion.  We found the synthesis of creatine 
kinase (CK) and skeletal muscle myosin light chain 
was reversibly induced in cells in 20%  FBS treated 
with PT, but no increased synthesis was seen in cells 
treated with CT or in control cells; Northern  analysis 
indicated this induction was at the level of mRNA.  In 
cells shifted to 0.5 % FBS, CT inhibited the normally 
induced synthesis of CK whereas PT potentiated it by 
'~50%.  Forskolin also inhibited growth in 20%  FBS 
and differentiation in 0.5%  FBS medium in a dose- 
dependent fashion.  Both forskolin and CT elevated 
cAMP levels compared with control or PT-treated 
cells, suggesting that CT is blocking proliferation and 
differentiation by elevating cAMP levels. These results 
establish that a PT-sensitive pathway is involved in 
regulating proliferation and differentiation  in BC3H1 
cells, and we postulate that PT functions by ADP 
ribosylating a G  protein that transduces  signals from 
growth factor receptors in these cells. 
c3n~ cells are  a  continuous,  nonfusing  muscle cell 
line (Schubert et al.,  1974). In response to reduced 
serum concentrations,  these cells stop proliferation 
and begin to express a family of proteins  including creatine 
kinase (CK), J myokinase,  nicotinic acetylcholine receptors, 
and skeletal and smooth muscle actin (Schubert et al., 1974; 
Munson et al.,  1982; Olson et al.,  1983a,b,  1984; Strauch 
and Rubenstein,  1984; Lathrop et al., 1985a; Strauch et al., 
1986; Wice et al.,  1987).  This process can be reversed  by 
the addition of high concentrations  of serum, and quiescent, 
differentiated cells will shut down the synthesis of these mus- 
cle proteins and reenter the cell cycle (Munson et al., 1982; 
Strauch  and Rubenstein,  1984; Lathrop et al.,  1985a). 
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Because these cells can transit  from a "proliferative" to a 
"differentiated" phenotype and back to the proliferative  phe- 
notype by manipulating  the growth conditions,  they provide 
an excellent  model system to study how signals  are trans- 
duced from cell surface receptors that  ultimately  result  in 
determining  whether a cell will proliferate  or differentiate. 
For example,  it has been demonstrated  that the addition  of 
acidic  or basic fibroblast  growth  factor  (FGF) to differen- 
tiated BC3H1 cells will cause them to shut down the synthe- 
sis of CK or actin mRNA (Lathrop  et al.,  1985b;  Wice et 
al.,  1987).  It has also been shown that purified  epidermal 
growth factor (EGF) will shut down the synthesis of CK or 
actin in differentiated  cells (Wang and Rubenstein,  1988). 
G proteins may play a key role in such signal transduction 
mechanisms.  The G proteins comprise a  family  of mem- 
brane-associated,  GTP-binding  proteins  that are believed to 
transduce  signals from extracellular  receptors to intracellu- 
lar effector molecules (for reviews see Gilman,  1984, 1987). 
Two of these proteins,  Gs and  Gi,  have been extensively 
characterized  as linking stimulatory  and inhibitory hormone 
receptors,  respectively, to adenylate cyclase (for reviews see 
Smigel  et al.,  1984; Gilman,  1984,  1987; Lefkowitz  and 
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mulate linking G proteins to growth factor receptors and the 
hydrolysis of inositol phosphates (Taylor,  1986; Taylor and 
Merritt,  1986).  For example, pertussis toxin (PT),  which 
catalyzes the ADP ribosylation of several G proteins, blocks 
thrombin-induced inositol phosphate formation and thymi- 
dine incorporation in lung fibroblasts (Paris and Pouyssegur, 
1986; Magnaldo et al., 1986; Chambard et al.,  1987; Paris 
et al., 1987), and attenuates c-myc expression stimulated by 
bombesin in 3T3 cells (Letterio et al.,  1986). 
Little is known about the regulation of G proteins or the 
roles of G proteins in skeletal muscle cell development al- 
though both PT and cholera toxin (CT) substrates have been 
identified in skeletal muscle sarcolemmal and T-tubule frac- 
tions (Scherer et al.,  1987).  It has also been reported that 
both PT and CT substrates decrease in amount as L6E9 myo- 
blasts  fuse and differentiate (Morris and Bilezikian, 1986). 
In addition, the ras oncogene, a GTP-binding protein with 
significant homology to the alpha subunit of transducin and 
Go (Hurley et al., 1984; Lochrie et al., 1985; Tanabe et al., 
1985), has been implicated in the regulation of myogenesis. 
Transfection of C2 muscle cells with oncogenic Harvey ras 
or N ras completely blocked fusion and myogenic differenti- 
ation (Olson et al., 1987; Gossett et al., 1988). We have also 
found that oncogenic Harvey ras would block differentiation 
in transfected BC3H1 cells (Kelvin et al., 1987; Kelvin et al., 
1989), and similar results have also been reported by Payne 
et al. (1987).  These results implicate the GTP-binding ras 
protein as being potentially involved in signaling pathways 
that regulate muscle cell proliferation and differentiation. To 
further investigate the potential role of G proteins in myogen- 
esis, we report here on the effects of CT and PT on prolifera- 
tion and differentiation in BC3H1 muscle cells. While both 
toxins inhibit proliferation,  PT induces differentiation where- 
as CT inhibits it. 
Materials and Methods 
Cell Culture 
BC3HI  mouse muscle cells (Schubert  et  al.,  1974),  obtained  from the 
American Type Culture Collection (Rockville, MD), were cultured in DME 
with 1 g/liter glucose supplemented with 20% FBS, penicillin (100 U/ml), 
and streptomycin (100 #g/ml). To induce differentiation, ceils were switched 
to the same medium containing 0.5%  FBS. 
Proliferation 
[3H]Thymidine incorporation was determined as previously described (Kel- 
vin et al.,  1986,  1988). For cell counts, cells plated at 2  x  104/35-mm tis- 
sue culture dish were switched 24 h later to fresh medium containing drugs 
as indicated in Fig. 2. At daily intervals, triplicate test dishes were rinsed 
once with PBS and I ml of  0. 1% crystal violet in 0.1 M citric acid was added. 
Cells were removed with a  rubber policeman and counted in a  hemacy- 
tometer. 
ADP Ribosylation 
A "membrane-rich fraction" was prepared from proliferating BC3H1 cells 
by a modification of the protocol of Imboden et al. (1986). Cells were plated 
at 2  ×  106/100-ram  dish; 24 h later cells were preincubated (if necessary) 
in varying concentrations of CT or PT for 4  h at 37°C in a  total  vol of 3 
ml. Each plate was rinsed with 5 ml cold PBS, and cells were removed with 
0.25%  trypsin, pelleted for 2  rain in an Eppendorf microfuge, (made by 
Brinkman Instruments, Inc., Westbury, NY) and resuspended in 1 ml cold 
lysis buffer containing 150 mM Tris-HCl, pH Z5,  6  mM EDTA, 6  mM 
dithiothrietol (DTT), and 0.2 p.g/ml  PMSE  The lysis buffer was made up 
fresh each time from separate stock solutions. Cells were incubated on ice 
for 2  min, sonicated at  100  W  for  5  s  on a  Braunsonic  1510 sonicator 
(B-Braun Instruments, Bethlehem, PA) equipped with a  microprobe, and 
centrifuged at 500 g for 10 min. The pellet was discarded and the superna- 
tant centrifuged at 100,000 g for 60 min (SW 55Ti rotor; Beckman Instru- 
ments, Inc., Palo Alto, CA). The final pellet (~membrane-rich fraction") was 
resuspended in 75  t~l of 200 mM PO4  buffer, pH 7.5,  and protein deter- 
mined by a colorimetric protein assay method (Bio-Rad Laboratories, Rich- 
mond, CA). 
For  the  ADP  ribosylation  assay  (adapted  from  Ribeiro-Neto  et  al., 
1985),  100/zg of total protein from the membrane-rich fraction was diluted 
with an equal volume of ribosylation buffer in a microfuge tube (final con- 
centration, 20 mM thymidine, 2 mM ATP, 2 mM GTP, 2.5 mM MgCI2, 
2 mM EDTA, 2 mM DTT, and 0.2/~g/ml of DNase 1). Ribosylation buffer 
was made fresh each time from separate stocks. CT and PT were activated 
by incubation with 25 mM DTT in PO4 buffer, pH 7.4, at 37°C for 30 min 
(Hildebrandt et al.,  1982,  1983; Moss et al.,  1983) and added at a concen- 
tration of 10 p.g/ml for PT and 20 p.g/ml for CT.  I #Ci/sample [32p]NAD  + 
(Sp act, 289 Ci/mmol; ICN Radiochemicals, Div.  ICN Biomedicals Inc., 
lrvine, CA) was added (0.07 ~M NAD  ÷) and tubes were incubated at 37°C 
for 30 min. To stop the reaction,  1.8 ml of 10% TCA was added, and tubes 
were placed at -20°C for 15 min. Tubes were centrifuged for 1 min, the 
supernatant was gently removed, and remaining liquid removed with tissue. 
Pelleted samples were resuspended in 30 t~l of 50 mM Tris-HCI, pH 8.0, 
30/~1 electrophoresis sample buffer containing 10% 2-mercaptoethanol was 
added, pH was adjusted to neutrality with 1 N HCI, tubes were placed in 
a boiling water bath for 5 min, and samples loaded onto a  10% acrylamide 
gel.  Proteins were electrophoretically  separated in the presence of SDS 
(Laemmli, 1970), and the gel was stained with Coomassie Brilliant Blue 
R-250,  destained,  dried,  and  autoradiographed.  A  low  molecular  mass 
marker kit (Bio-Rad Laboratories) was used to establish a standard curve. 
Kodak X-OMAT AR film was exposed at  -70°C and developed in Kodak 
GBX-2 developer. 
Differentiation 
For the measurement of CK, cells were gently rinsed with cold PBS, pH 
7.4, removed with 0.25 % trypsin, and CK activity was determined as previ- 
ously described (Simard and Connolly,  1987). 
Myosin was examined in cell extracts after electrophoresis in 10% acryl- 
amide gels (Laemmli, 1970) and electrophoretic transfer to nitrocellulose 
(Towbin et al.,  1979).  Blots were rehydrated in TBS, pH 8.0,  containing 
0.05%  Tween 20 (TBST),  and incubated for 30 min in TBST containing 
10%  normal goat serum. Blots were then incubated with myeloma culture 
supernatants (designated QBM-2) diluted 1:75 in TBST. The QBM-2 anti- 
body (Merrifield et al.,  1983)  reacts with myosin light chains. After over- 
night incubation, blots were washed three times for 5 rain each in TBST, 
and incubated in alkaline phosphatase-conjugated rabbit anti-mouse lgG 
(1:7,500 dilution; Promega Biotec, Madison, WI) for 30 min. Blots were 
washed three times for 5 min each in TBST, the color reaction was initiated 
by  the addition of fresh nitro blue tetrazolium and 5-bromo-4-chloro-3- 
indolyl phosphate substrate, and the reaction terminated by the addition of 
20 mM Tris, pH 8.0, containing 5 mM EDTA. For myosin  heavy chain, blots 
were incubated with a polyclonal chicken anti-fetal calf myosin heavy chain 
serum (Jandreski and Liew,  1984) followed by rabbit anti-chicken IgG, and 
alkaline  phosphatase-conjugated goat  anti-rabbit  IgG  (1:7,500  dilution; 
Promega Biotec, Madison, WI). 
cAMP Measurements 
Cells were grown in 6 x  35-mm cluster well plates and incubated with drugs 
or control medium as indicated in Fig. 7. To determine cAMP levels, cells 
were washed once in ice cold PBS, 1.0 ml/well 0.01 N HCI containing iso- 
butyl methyl xanthine at 1 mM was added for 60 min, and this HC1 extract 
was stored at -20°C until cAMP was determined by RIA (Teitelbaum and 
Berl, 1986).  This assay was done using a cAMP RIA kit from New England 
Nuclear (Boston, MA) or Biomedical Technologies, Inc. (Stoughton, MA). 
We used the acetylated assay. At each timepoint, four independent cAMP 
determinations were made and two wells were used for protein determina- 
tions. 
Northern Analysis 
Cytoplasmic RNA was isolated by the method of Rasmussen et al. (1987) 
from proliferating (20% FBS medium) or differentiated (0.5% FBS medi- 
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lane on a 1% agarose gel containing 6.7 % formaldehyde, transferred to Zeta- 
probe, and cross-linked by UV exposure. Blots were prehyhridized for 6 h 
at 42°C in 50% formamide containing 0.75 M NaCI, 50 mM Na phosphate, 
pH 6.5, 0.5% skim milk powder, 1% SDS, 1% glycine, 5 mM EDTA, and 
500 #g/ml yeast total RNA, and hybridized for 16-24 h under the same con- 
ditions with 25 ng of R21  CK plasmid (Roman et al.,  1985)  labeled with 
3~p by the method of Feinberg and Vogelstein (1983),  washed under high 
stringency conditions at 50°C, and autoradiographed. 
Materials 
Dibutyrl cAMP and forskolin were from Sigma Chemical Co. (St. Louis, 
MO), and PT and CT from List Biological Laboratories (Campbell, CA). 
Forskolin was diluted into medium from a stock solution of 5  ×  10  -2 M 
in 50% ethanol; all other reagent stocks were made up in sterile water and 
diluted into medium. 
Results 
When BC3H1  membranes were incubated with [32p]NAD+ 
in the presence of activated CT, three proteins with apparent 
molecular masses of 35--43  kD were ADP ribosylated (Fig. 
1 A). This ribosylation is CT specific and intracellular:  it is 
inhibited in a dose-dependent fashion by preincubation of in- 
tact cells with CT although the two lower molecular mass 
species appear to be more sensitive to preincubation than the 
43-kD peptide (Fig.  1 A). Three high molecular mass pro- 
teins are also present on this autoradiogram although these 
are not specifically ribosylated by CT as they are also seen 
to be labeled in its absence. In cells treated with PT, a single 
species at 40 kD is seen to be ribosylated (Fig. 1 B), and this 
protein may represent the o~ subunit of Gi (Ui,  1984).  This 
ribosylation is also inhibited in a dose-dependent fashion by 
preincubation of intact cells with PT (Fig.  1 B). 
Treatment of exponentially growing BC3H1 cells with CT 
(Fig. 2 a) and PT (Fig. 2 b) inhibits [3H]thymidine incorpo- 
ration in a dose-dependent fashion.  In this experiment, we 
saw m73 % inhibition of thymidine incorporation with PT at 
a dose of 10 ng/ml after 48 h. Higher doses did not depress 
thymidine incorporation further (data not shown). In a series 
of eight separate experiments, [3H]thymidine incorporation 
was inhibited by 69  +  9.7 % at 10 ng/ml of toxin. With CT, 
we obtained an inhibition of 54% at 10 t~g/ml after 48 h. In 
a series of eight separate experiments, the mean reduction in 
thymidine incorporation was 61  +  12%.  This reduction in 
[3H]thymidine incorporation is not due to an inhibitory ef- 
fect of either toxin on thymidine uptake but rather reflects a 
true reduction in the rate of proliferation of these cells (Fig. 
2  c).  Furthermore,  these toxins are not merely killing the 
cells; no significant number of cells was detached from the 
culture dish by either toxin over 3-4 d, and >95 % of either 
control, PT- or CT-treated cells would exclude trypan blue 
(data  not  shown).  That these  agents  are  not  toxic  is  also 
demonstrated by  [~H]thymidine  rescue by specific growth 
factors (Kelvin et al.,  1989). 
BC3H1 cells proliferate in 20% FBS (growth medium) and 
have a  fibroblast-like morphology; when switched to 0.5% 
FBS (differentiation medium), cells stop proliferating, have 
a more elongated, myoblast-like appearance, and synthesize 
muscle-specific proteins (Munson et al., 1982). Both CT and 
PT have reduced proliferation of BC3H1 cells. Do these cells 
differentiate? PT-treated BC3H1 cells growing in 20% FBS 
medium (growth medium) have a myoblast-like morphology. 
In contrast, CT-treated cells retain a fibroblast-like appear- 
ance (data not shown). We monitored biochemical differenti- 
Figure 1. This autoradiogram illustrates substrates ADP ribosylated 
by (A) CT or (B) PT in BC3H1 cells.  (A) Three bands of 35-43 
kD were specifically ADP ribosylated by CT and this ribosylation 
was blocked by preincubation of intact cells with increasing doses 
of CT. (B) A single prominent species at 40 kD was ADP ribosyl- 
ated by PT, and this could be blocked by preincubation  of intact 
cells with increasing doses of PT. 
ation by measuring steady-state levels of CK. In 20% FBS, 
no significant amount of CK was noted in untreated, control 
cultures (Fig. 3 a). Similar very low levels of CK were seen 
in cells in 20% FBS treated with varying doses of CT for 4  d 
(Fig. 3 a). However, a dose-dependent rise in CK levels was 
noted in PT-treated cells in 20%  FBS after 4  d  (Fig.  3 a). 
In 0.5 % FBS, CK levels were up 10-20-fold in control cells 
over the 4 d of this assay compared with cells maintained in 
20%  FBS (Fig.  3, a  and b).  In CT-treated cells, there was 
an inhibition of CK accumulation in 0.5 % FBS (Fig.  3 b). 
Higher doses did not inhibit CK levels further,  and in five 
separate experiments, an average reduction of 53  +  4 % was 
noted compared with CK levels in control cells in 0.5%. On 
the other hand,  CK levels were potentiated  in  a  dose-re- 
sponse fashion by PT (Fig. 3 b); in five different experiments, 
an increase of 49  +  27 % was noted in addition to the level 
of CK seen in control 0.5%  FBS cells. 
Fig.  4  shows the timecourse of this response at a  single 
toxin dose. We saw a gradual rise in CK levels in 20% cells 
treated with PT (10 ng/ml), whereas no CK induction  was 
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Figure 2. Cell growth of toxin-treated BC3HI cells. Exponentially 
growing cells in 20% FBS were treated with varying doses of PT 
(a) or CT (b) for 48 h and [3H]thymidine incorporation was deter- 
mined. Both PT and CT treatment resulted in significant inhibition 
of thymidine incorporation. In both of these experiments and in all 
subsequent figures showing thymidine incorporation data, the val- 
ues used to calculate percentages were the mean of quadruplicate 
samples. In all cases, the control value (no drug) was taken as 100% 
and samples were treated with PT or CT expressed as a percentage 
of this control value. (c) Both CT and PT result in a significant 
reduction in the number of cells with time. 
seen with 20%  control cells (Fig. 4 a).  The appearance of 
CK in 0.5%  FBS in the presence of PT was very similar to 
that seen in control cells for the first 3 d of the experiment, 
but after 4 and 5 d there was significantly higher enzyme ac- 
tivity in toxin-treated cells (Fig. 4 a). In CT (10/xg/ml), no 
CK was detectable in 20%  cells (data not shown);  in 0.5% 
FBS,  a  pronounced  inhibition  of CK production was seen 
over the 5 d of the experiment, and this was also most ap- 
parent  at 4  and  5  d  after the  shift to 0.5%  FBS  medium 
(Fig.  4 b). 
To investigate the possibility that CK synthesis could be 
uniquely affected by these drug treatments, we assessed myo- 
sin expression in toxin-treated cells using an immunoblot as- 
say with  the  QBM-2  monoclonal  antibody.  This antibody 
reacts with skeletal muscle myosin but not smooth muscle or 
nonmuscle myosin (Merrifield et al.,  1983).  We found that 
PT treatment for 4 d in 20% FBS induced significant levels 
of myosin light chain expression (Fig. 5). No signal is detect- 
able in cells growing in 20% FBS (Fig. 5), or in cells treated 
with CT (data not shown).  A  similar result was observed 
with  a  polyclonal  antibody  against  cardiac  myosin heavy 
chain (Jandreski and Liew, 1984). Significant levels of myo- 
sin  heavy  chain  synthesis  were  detected  in  BC3HI  cells 
grown in 20% FBS and treated with PT but not in 20% con- 
trol cells (data not shown). 
These results indicate that both PT and CT inhibit prolifer- 
ation, but only PT induces muscle-specific protein synthesis. 
How could PT and CT be exerting these differential effects? 
CT treatment increases cAMP levels in a variety of cell types 
(Gill,  1977). Therefore, we tested the effect of other agents, 
known to affect cAMP levels, on proliferation and differenti- 
ation in BC3H1 cells.  10  -4 M forskolin inhibited [3H]thymi- 
dine incorporation in 20% FBS by 81% (Fig. 6 a). CK levels 
in forskolin-treated cultures in 0.5 % FBS were dramatically 
lower than control cells in 0.5 % FBS and almost identical to 
those seen in control cells in 20% FBS (Fig. 6 b). Treatment 
of cells with 0.5 % ethanol (final level of ethanol in forskolin- 
treated cultures at 10  -4 M) had no significant effect on CK 
or [3H]thymidine incorporation (data not shown).  Dibutyrl 
cAMP also inhibited  [3H]thymidine incorporation (in 20% 
FBS) and CK expression (in 0.5 % FBS) in a dose-dependent 
fashion (data not shown). 
Both  CT and  forskolin rapidly elevated cAMP levels in 
these cells, and an approximate fourfold increase in cellular 
levels was seen with these two drugs by 60 min (Fig.  7). 
However, there was no significant difference between control 
and  PT-treated  cells.  Over 4  d,  the  total  level  of cAMP 
dropped in both control and treated cultures (in particular 
between 2 and 4 d in CT- and forskolin-treated cultures) al- 
though these cells continued to express much higher levels 
of cAMP than did control cells. There was no significant dif- 
ference between control and PT-treated cells over the course 
of the experiment. These results suggest that elevated cAMP 
levels are inhibitory to both proliferation and differentiation 
in BC3H1  cells. 
How  then  does  PT  inhibit  proliferation  but  allow  for 
differentiation? If cells in 20% FBS are treated with PT, and 
the PT is removed, there is a rapid reversal in the steady-state 
levels of CK (Fig.  8). This induction of differentiation is at 
the mRNA level. When  cells are incubated in high serum 
(20%  FBS)  in the presence of PT (10  ng/ml),  analysis of 
RNA  isolated  from BC3HI  cells indicates  that  significant 
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Figure 3. CK expression  in toxin-treated  cultures 
in (a) growth or (b) differentiation  medium. Cells 
were plated at  1 x  105/35-mm dish in 20% FBS 
and switched 24 h later to fresh 20% FBS medium 
containing varying doses of PT or CT. (a) Control 
cells in 20%  FBS showed  little CK activity, but 
there was a dose-dependent induction of CK by PT 
though not by CT. (b) Control cells in 0.5% FBS 
differentiate  and express  high levels of CK. This 
was potentiated in a dose-dependent fashion by PT 
but inhibited by ",,50% by CT. For each toxin dose 
in this experiment,  and in all subsequent figures in 
which CK activity  was measured, triplicate  sam- 
ples  were tested,  and the points shown  represent 
means  +  SD. 
levels of CK mRNA are seen in PT-treated cells. Little or no 
message was detected in control cells grown in 20% FBS or 
in 20%  FBS plus CT, but this mRNA was clearly induced 
in control cells switched to 0.5 % FBS (Fig. 9). These results 
suggest that a  PT-sensitive  pathway conducts signals  from 
some factor in the serum that affects proliferation and dif- 
ferentiation. 
Discussion 
In this  study we have demonstrated  that  both PT and CT, 
which ADP ribosylate the c~ subunits of Gi and Gs respec- 
tively, inhibit proliferation in BC3H1 muscle cells in a dose- 
dependent  fashion.  However,  PT induces differentiation of 
these cells, whereas CT inhibits it.  This induction of differ- 
entiation by PT is time and dose dependent.  CK as well as 
both myosin light and heavy chains are induced by PT. Previ- 
ous work on this  cell  line has  indicated  that very little  or 
no muscle-specific protein synthesis or mRNA could be de- 
tected in BC3H1 cells growing in 20% FBS (Munson et al., 
1982; Olson et al.,  1983a, b, 1984; Strauch and Rubenstein, 
1984; Strauch et al.,  1986; Spizz et al.,  1986; Wice et al., 
1987). Thus, the fact that we detect significant levels of myo- 
sin and CK protein, and CK mRNA in 20% FBS cells treated 
with PT indicates that there is a specific PT induced intitia- 
tion of muscle cell differentiation. 
CT ADP ribosylates a  series of at least three proteins in 
the 35-43-kD molecular mass range in BC3H1 membranes. 
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Figure  4.  Timecourse of CK expression in toxin-treated cultures. 
Cells were plated at  1  x  105/35-mm dish in 20%  FBS medium 
and 24 h later switched to fresh 20%  or 0.5%  FBS containing (a) 
PT at 10 ng/ml or (b) CT at 10 #g/ml. (a) Compared with control 
cells, there was a significant induction of CK expression by PT in 
both 20%  FBS and 0.5%  FBS. (b) In cultures switched to 0.5% 
FBS, CT inhibited the increase in CK expression seen in control 
cells by •50%. 
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Figure  6. Forskolin effects on proliferation and differentiation. (a) 
Forskolin inhibits [3H]thymidine incorporation in a  dose-depen- 
dent fashion in 20%  FBS medium. (b) In cells switched to 0.5% 
FBS to induce differentiation, the expression of CK was inhibited 
in a dose-dependent fashion by forskolin. 
Figure  5.  Myosin light chain 
expression in PT-treated BC3- 
H1 cells. Lanes 1 and 2, con- 
trol cells in 20% FBS; lanes 3 
and 4, cells in 20 % FBS +  PT 
(10 ng/ml for 4 d); lane 5, rat 
skeletal muscle myosin (RM). 
Lanes 1 and 3 contain 40 #g 
and lanes 2 and 4 contain 10 
#g  of cell extract.  Immuno- 
blots probed with the QBM-2 
antibody demonstrate that myo- 
sin light chain expression has 
been induced in 20% FBS me- 
dium  by  treatment  with  PT, 
whereas no expression is seen 
in control cells. 
CT has been shown to ADP ribosylate the c~ subunit of Gs, 
which has an apparent molecular mass of ,,o45  kD in sever- 
al different systems (Gilman,  1984,  1987).  Little is known 
about  the  G  proteins in  skeletal muscle;  however,  similar 
results were reported for the L6E9 myoblast line (Morris and 
Bilezikian,  1986)  where CT was shown  to ADP ribosylate 
three bands  in  the  39-45-kD  range.  Scherer et  al.  (1987) 
have reported two proteins of 42 and 62  kD ribosylated by 
CT  in  skeletal muscle  sarcolemmal membranes.  The pro- 
teins we have described may represent the muscle equiva- 
lent(s) of Gs,  although biochemical purification and char- 
acterization of the G  protein family from this cell line will 
be required to establish this point. However, it is clear that 
substrates ADP ribosylated by CT in BC3H1  cells are intra- 
cellular,  associated  with  the  membrane,  and  specifically 
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Figure 7. cAMP determinations in BC3H1 cells. 24 h after plating, 
cells were switched to fresh 20%  FBS medium containing either 
forskolin (10  -4 M) or CT (10 #g/ml).  Both forskolin and CT in- 
duced a significant rise in cAMP levels within 60 min, whereas PT- 
treated cells were indistinguishable from control cells. Values rep- 
resent mean of four separate samples. 
ribosylated since this labeling can be eliminated by preincu- 
bation of intact cells with toxin. 
We have presented data that elevated cAMP levels are in- 
hibitory to both proliferation and differentiation in this cell 
line based on the use of CT, dibutyrl cAMP,  and forskolin 
as well as direct measurements of cytoplasmic cAMP. There 
are a  variety of different reports with respect to a  role for 
cAMP  in  muscle  cell  differentiation.  Stygall  and  Mirsky 
(1980)  reported that CT would induce differentiation in pri- 
mary rat myoblast cultures.  They found this treatment also 
resulted in elevated cAMP levels and reported that dibutyrl 
cAMP would also stimulate fusion.  In contrast,  several re- 
ports have found that high levels of dibutyrl cAMP or ele- 
vated cAMP would inhibit fusion (Zalin,  1973;  Wahrmann 
et al.,  1983; Entwistle et al.,  1986) but did not block CK in- 
800- 
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Figure 8. Reversal of CK induction by PT. BC3H1 cells were plat- 
ed at  1  x  10V35-mm dish  in 20%  FBS. 24 h later, cells  were 
switched to fresh medium containing 10 ng/ml PT. By 5 d after PT 
addition, cells were expressing high levels of CK in 20% FBS. If 
cells were left in PT-containing medium, they continued to express 
high levels of CK.  However, removal of PT and transfer to fresh 
20% FBS medium resulted in a rapid drop in the steady-state levels 
of CK. 
Figure  9.  Northern  analysis  of 
creatine  kinase mRNA in toxin- 
treated  BC3H1 cells.  Cytoplas- 
mic RNA was isolated from cells 
grown in 20% FBS or from cells 
switched to 0.5%  FBS  for 4  d. 
Cells were incubated with PT or 
CT for 96 h in 20% FBS. 10 #g of 
cytoplasmic  RNA  per lane  was 
subjected  to  electrophoresis  in 
a formaldehyde-agarose  gel and 
transferred  to  Zeta  probe.  The 
blot was hybridized with the R21 
CK 32P-labeled probe and  auto- 
radiographed. 
duction (Zalin,  1973). It has been suggested that a transient 
rise in cAMP levels is an inductive factor in fusion (Zalin and 
Montague,  1974) although this has been disputed, and these 
workers reported that cAMP levels rise after fusion and be- 
fore the  initiation  of CK synthesis in  primary chick myo- 
blasts (Schutzle et al., 1984). In our hands, CT did not block 
the fusion of primary chick myoblasts or of the mouse C2 
muscle cell line (data not shown), but we have shown in this 
report that CT clearly inhibits differentiation in BC3H1 ceils. 
This discrepancy may reflect differences between  the  cell 
lines,  and/or  may  reflect  the  fact that  signaling  pathways 
differ in primary muscle cells, which permanently differenti- 
ate, versus BC3H1 cells, which retain the capacity to reenter 
the cell cycle. 
Preliminary experiments have indicated that FGF can re- 
store control levels of [3H]thymidine incorporation in CT- 
treated BC3H1 cells (data not shown) suggesting that CT is 
not capable of blocking all growth factor receptor-mediated 
signals.  Thus,  we believe that CT is  exerting its  effect on 
BC3H1 cells by ADP ribosylating Gs and raising cAMP lev- 
els.  We are currently  examining the  relationship between 
cAMP levels and growth  factor regulation  of proliferation 
and differentiation. 
PT ADP ribosylates a  very prominent 40-kD species in 
BC3H1  cell membranes, and this labeling is eliminated by 
preincubation of intact cells with PT.  Similar results were 
also  reported  for L6E9 myoblast membranes (Morris and 
Bilezikian,  1986)  although  a  number of other bands were 
also labeled and it was not clear if this labeling could be elim- 
inated  by  preincubation  of intact  cells  with  toxin.  These 
authors also reported that levels of substrate ADP ribosylated 
by PT decreased during differentiation in L6E9 myoblasts; 
in contrast,  we observed no marked change in the amount 
of substrate  in  differentiated  BC3H1  cells  (Fig.  7,  Kelvin 
et al.,  1989).  This difference may reflect the fact that one 
of these cell  lines  (L6E9)  fuses and terminally differenti- 
ates, whereas the other (BC3H1) cell line retains the capacity 
to reenter the cell cycle. However, it has also been demon- 
strated that the level of substrate ADP ribosylated by PT in- 
creased severalfold during DMSO-induced terminal differ- 
entiation in HL-60 cells (Oinuma et al.,  1987)  and during 
the conversion of 3T3-LI cells from a fibroblast to an adipo- 
cytelike phenotype (Watkins et al.,  1987).  To begin to ana- 
lyze any potential role for the PT-ribosylated substrate(s) will 
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ferentiation. 
PT  will  block  hormone  activation  of adenylate  cyclase 
(Gilman,  1984,  1987; Anand-Srivastava  et al., 1987; Kassis 
et al.,  1987).  In  addition,  PT will block proliferative  re- 
sponses stimulated  by growth factors that presumably work 
through  phospholipase  C  and  inositol phosphate  turnover 
(Paris and Pouyssegur,  1986;  Chambard et al.,  1987;  Paris 
et al.,  1987;  Leterrio et al.,  1987).  Although the PT-ribo- 
sylated substrate in both the adenylate cyclase system and the 
inositol phosphate  systems are very similar in size and struc- 
ture (for examples, Brass  et al.,  1986;  Wojcikiewicz et al., 
1986;  Aub et al.,  1986;  Kikuchi et al.,  1986;  Chambard et 
al., 1987), they are not identical. We speculate that PT works 
in BC3H1  cells by blocking a signal from serum since ceils 
in 20%  FBS plus PT will differentiate  even though  all the 
necessary factors to promote proliferation and inhibit differ- 
entiation are present, and these cells do not have elevated lev- 
els of cAMP.  Thus, we predict that the PT substrate in these 
cells will be associated with a growth factor  receptor that 
does not work through  activation  of adenylate  cyclase. 
An alternate explanation is that the ADP ribosylation event 
mediated by PT is actually a positive signal to differentiate. 
This  has  been  proposed  from  studies  on  hematopoietic 
differentiation  in which inhibitors of ADP ribosylation could 
block the commitment and/or differentiation  of stem cells 
(Dexter et al.,  1985).  However, as outlined in Kelvin et al. 
(1989), the fact that specific growth factors can overcome the 
PT effects  argues  against  the ADP ribosylation event itself 
being an important  signal. 
Pouyssegur and co-workers have recently shown that two 
growth factors,  FGF and thrombin,  acting through indepen- 
dent  pathways  can  induce  [3H]thymidine  incorporation  in 
lung fibroblasts  (Paris  and Pouyssegur,  1986;  Magnaldo et 
al.,  1986;  Chambard et al.,  1987; Paris et al.,  1987).  How- 
ever, only one of these pathways is blocked by PT.  Similar 
results  were also reported  for bombesin and PDGF stimu- 
lation  in 3T3 cells (Letterio et al.,  1987).  Thus,  in BC3H1 
cells, there may be more than one pathway to regulate prolif- 
eration  and/or differentiation  and  PT may  be  exerting  its 
effect by blocking signals in one of these pathways. In the ac- 
companying  report we examine the effect of PT on growth 
factor-mediated  signaling  pathways.  Based  on the  present 
data, we conclude that there is a PT-sensitive signaling path- 
way in these cells and this pathway is involved in the trans- 
duction of signals that regulate proliferation and differentia- 
tion in BC3H1  cells. 
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